These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30529931)

  • 21. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of small molecular inhibitors for efflux protein Rv2688c of Mycobacterium tuberculosis.
    Vadija R; Mustyala KK; Malkhed V; Dulapalli R; Veeravarapu H; Malikanti R; Vuruputuri U
    Biotechnol Appl Biochem; 2018 Jul; 65(4):608-621. PubMed ID: 29377374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Novel Enhancers of Isoniazid Toxicity in
    Lentz F; Reiling N; Martins A; Molnár J; Hilgeroth A
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
    Sharma S; Kumar M; Sharma S; Nargotra A; Koul S; Khan IA
    J Antimicrob Chemother; 2010 Aug; 65(8):1694-701. PubMed ID: 20525733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking analysis insights quercetin can be a non-antibiotic adjuvant by inhibiting Mmr drug efflux pump in Mycobacterium sp. and its homologue EmrE in Escherichia coli.
    Suriyanarayanan B; Sarojini Santhosh R
    J Biomol Struct Dyn; 2015; 33(8):1819-34. PubMed ID: 25297690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.
    Rodrigues L; Villellas C; Bailo R; Viveiros M; Aínsa JA
    Antimicrob Agents Chemother; 2013 Feb; 57(2):751-7. PubMed ID: 23165464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR.
    Jiang X; Zhang W; Zhang Y; Gao F; Lu C; Zhang X; Wang H
    Microb Drug Resist; 2008 Mar; 14(1):7-11. PubMed ID: 18321205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors.
    Rodrigues L; Aínsa JA; Amaral L; Viveiros M
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):118-27. PubMed ID: 21517739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis.
    Yamamoto K; Nakata N; Mukai T; Kawagishi I; Ato M
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.
    Adams KN; Szumowski JD; Ramakrishnan L
    J Infect Dis; 2014 Aug; 210(3):456-66. PubMed ID: 24532601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein.
    Malkhed V; Mustyala KK; Potlapally SR; Vuruputuri U
    J Biomol Struct Dyn; 2014 Dec; 32(12):1889-906. PubMed ID: 24124990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human proton pump inhibitors inhibit
    Lake MA; Adams KN; Nie F; Fowler E; Verma AK; Dei S; Teodori E; Sherman DR; Edelstein PH; Spring DR; Troll M; Ramakrishnan L
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2215512120. PubMed ID: 36763530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c.
    Singh K; Kumar M; Pavadai E; Naran K; Warner DF; Ruminski PG; Chibale K
    Bioorg Med Chem Lett; 2014 Jul; 24(14):2985-90. PubMed ID: 24894561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase-a molecular modelling perspective.
    Tembe N; Machaba KE; Ndagi U; Kumalo HM; Mhlongo NN
    J Mol Model; 2022 Jan; 28(2):35. PubMed ID: 35022913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
    Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
    J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.
    Viveiros M; Martins M; Rodrigues L; Machado D; Couto I; Ainsa J; Amaral L
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):983-98. PubMed ID: 23106274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
    Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
    Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.